Search

everythinglearnresearchcommunity

for

Search:↓

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

TPA is about 50 times more effective at promoting tumors than MZ.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Researchers made new compounds that could potentially be developed into anticancer drugs.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Curcumin spanlastics are the most effective for cancer therapy due to their strong antimicrobial, antioxidant, and antitumor effects.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.

Most patients experienced significant but reversible hair loss during treatment.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Topical alpha-terthienyl with UVA may safely treat psoriasis without cancer risk.